Gene therapy gets FDA approval -- and a $2 million price tag
The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: Food and Drug Administration (FDA) | Gene Therapy | Genetics | Health | Spinal Muscular Atrophy